APA (7th ed.) Citation

Perakakis, N., Chrysafi, P., Feigh, M., Veidal, S. S., & Mantzoros, C. S. (2021). Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. MDPI AG.

Chicago Style (17th ed.) Citation

Perakakis, Nikolaos, Pavlina Chrysafi, Michael Feigh, Sanne Skovgard Veidal, and Christos S. Mantzoros. Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. MDPI AG, 2021.

MLA (8th ed.) Citation

Perakakis, Nikolaos, et al. Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. MDPI AG, 2021.